American Injectables Earns FDA Approval
"This is a transformative achievement for our organization," said
Setting a New Standard for Excellence
FDA approval signifies more than regulatory compliance — it represents American Injectables' dedication to innovation, quality, and reliability in pharmaceutical manufacturing. This milestone positions the company as a trusted partner for pharmaceutical companies seeking scalable and compliant sterile injectable solutions.
"Our team's focus on operational excellence and continuous improvement was instrumental in achieving this approval," Allen added. "This success is a testament to the incredible talent and commitment of everyone at American Injectables."
About American Injectables
American Injectables is a privately held contract development and manufacturing organization (CDMO). They specialize in ready-to-use glass or plastic vials and ready-to-use nested syringes.
In addition to manufacturing, American Injectables excels in formulation optimization, analytical and stability services, and process engineering. They are currently seeking partnerships and offer flexible terms as well as priority timelines.
Based in
Media Contact
Senior Vice President of Business Development
[email protected]
949-291-5102
View original content to download multimedia:https://www.prnewswire.com/news-releases/american-injectables-earns-fda-approval-302346191.html
SOURCE American Injectables Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ecopetrol Reports Cybersecurity Incident
- Co-Founder William Hoffmann Retires from Grotefeld Hoffmann & Gordon LLP
- WeRide Named Among China's Top 10 AI Case Studies for UAE Autonomous Driving Deployment, the Only Autonomous Driving Company Recognized
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share